fedratinib dihydrochloride monohydrate
SpainDrugs containing this active substance
-
It is used to treat adult patients with myelofibrosis (a rare type of blood cancer) who present with symptoms such as bone pain, weight loss, fever or night sweats, or who have an enlarged spleen.
Form: capsules, hard
Active substance Dosage fedratinib dihydrochloride monohydrate 117,3 mg Manufacturer: Bristol-Myers Squibb Pharma Eeig